Helping you stay current in drug monitoring

Come see us at the 3rd Opioid Management Summit

Quest Diagnostics ​is proud to be an executive partner of the 3rd Opioid Management Summit February 26-27, 2019 in Washington, DC.

Join us on February 26 at 10:30 AM as we present: Patterns of Drug Misuse in America and Reducing Risks by Implementing a System-Wide Drug Monitoring Protocol

While the drug misuse epidemic continues to be a public health crisis in the U.S. , the nature of the misuse is shifting. Misuse of some drugs shows signs of decline in certain populations, but explosive growth in others. Learn about the most recent trends on the evolving patterns of misuse, analyzed from over 3.9 million drug monitoring tests performed by Quest Diagnostics between 2011 and 2017 and how these insights can help better educate providers, improve patient care, and establish system-wide protocols for prescribing and monitoring controlled substances such as opioids, benzodiazepines, and amphetamines.

  • Assess the current drug misuse trends, including who is misusing and which drugs are increasingly prevalent
  • Learn about the benefits of clinical drug testing as an objective tool to help reduce risks associated with chronic use of controlled substances
  • Identify the elements to consider when implementing a responsible drug monitoring protocol across your organization